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Effects of changing salt and water balance on renal kallikrein,
kininogen and kinin. The kallikrein—kininogen—kinin system (KKK) has
been implicated in the renal sodium excretion response to changes in
dietary sodium. However, both increases and decreases in the activity
of this system have been observed when urinary sodium excretion is
augmented by a variety of maneuvers. To further evaluate the potential
physiologic role of this system, we measured three components of the
KKK system in urine. Total kallikrein, intact kininogen, and kinin were
measured twice in normal individuals during balance on both a high (250
mEq/day) or low (10 mEq/day) sodium intake. A consistent and
significant reduction in the activity of all three components of the KKK
system was noted during the high salt intake. Furthermore, during the
high sodium intake, further acute reductions in components of this
system were observed when an acute saline but not water load was
administered. The consistent response of the various components of the
KKK system to both acute and chronic sodium loading suggests that
the system is physiologically linked to the regulation of sodium balance.
However, the directional changes argue against a primary natriuretic
effect of this system.
Kinins are potent vasoactive peptides implicated in the
regulation of blood pressure, renal plasma flow, and renal salt
and water handling [1, 2]. Urinary kinins are generated from the
reaction of a substrate, low molecular—weight kininogen, with
renal kallikrein, a serine protease localized along the distal
nephron of the mammalian kidney [31. The specific function of
the kallikrein—kininogen—kinin (KKK) system in modulating
renal salt and water transport in man is not clear as activation of
this system has been described under conditions of both
antinatriuresis and natriuresis [4—fl].
Although it is kinin that exerts effects on vascular smooth
muscle cells and perhaps renal epithelial cells, the activity of
the KKK system has most often been evaluated by the mea-
surement of kallikrein in the urine. Such urinary measurements
may not accurately reflect the activity of kinins at physiologi-
cally important intrarenal sites. Furthermore, urinary pH and
ionic concentrations may alter the rate of formation and degra-
dation of kinins [7—10]. Nevertheless, by analogy to other renal
hormonal systems, urinary measurements of the various com-
ponents of this system may provide clues to the physiologic
importance of the system under various conditions.
Received for publication November 8, 1985
and in revised form April 14 and August 22, 1986
© 1987 by the International Society of Nephrology
The effect of acute and/or chronic salt and water loading on
urinary kallikrein excretion and activity in man has been
previously described [1,5, 11—17]. However, in the majority of
these studies, these measurements do not correlate with
simultaneously—measured urinary kinin excretion 11, 2, 18].
This lack of correlation emphasizes the inherent problems in
assessing possible physiologic relationships based upon the
measurement of only one component of the KKK system.
Few studies have also considered kininogen to be important
in the regulation of kinin formation. Our laboratory previously
suggested that urinary kininogen is a determinant of urinary
kinin generation and that alteration in urinary kininogen excre-
tion may account for disease specific abnormalities in kinin
excretion [19].
The present study was designed to evaluate the effects of
acute salt and water loading and chronic dietary salt manipula-
tion on simultaneously—measured total kallikrein, kininogen
and kinin in normal volunteers. By measuring multiple compo-
nents of this system, we hoped to more clearly define the
physiologic importance of this system in renal sodium and
water excretion. In addition, we hoped to establish the relative
importance and utility of kallikrein and kininogen measure-
ments in predicting changes in urinary kinin excretion.
Methods
Experimental protocols
All human studies were carried out at the Brown University
Clinical Research Center at the Roger Williams General Hos-
pital. Protocols were approved by the Ethics and Clinical
Investigations Committee and the Scientific Advisory Commit-
tee of both institutions. Informed consent was obtained from
each subject. Subjects had normal physical examinations and
no evidence of renal, liver, cardiac, or thyroid disease by
specific laboratory studies. All medications including over—the—
counter preparations were discontinued for at least one week
prior to the study.
The protocol consisted of three phases. The first two phases
were randomized and designed to evaluate the effects of chronic
sodium restriction and sodium loading on components of the
KKK' system. For both phases, daily weight, blood pressure
and urinary sodium excretion were monitored until subjects
achieved sodium balance. During the low sodium phases,
subjects were placed on a diet containing 10 mEq sodium, 60
mEq potassium, and 2 liters of fluid per day. Subjects were
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considered to be in balance when urine sodium excretion was
between 1 and 25 mEqlday, urine potassium excretion was
between 50 and 80 mEq/day and body weight was stable
(usually 4 to 6 days). After achieving sodium and potassium
balance, two 24-hour urines were collected for the determina-
tion of components of the KKK system, aldosterone, creati-
nine, sodium and potassium. On the morning of the second
urine collection, after being upright and ambulatory for four
hours, plasma was drawn for plasma renin activity and plasma
aldosterone concentration. During the high sodium phases, the
diet consisted of 250 mEq sodium, 60 mEq potassium and 2
liters of fluid per day. Subjects were considered to be in balance
when urine sodium excretion was between 210 and 290
mEq/day, urine potassium excretion was between 50 and 80
mEq/day and weight was stable.
All 24-hour urines were stored at 4°C while being collected
and then frozen at —70°C. The method of urine collection was
designed to minimize the loss of kinins and kininogen without
denaturing kallikrein [201. Subjects were encouraged to void at
least hourly throughout the day into a graduated beaker. We
have previously determined that bladder urine loses about 10%
of its kinin content over one hour [19]. This loss represents the
net effect of kininogen degradation by urine peptidases and
kinin degradation by kininases. After measuring the volume of
each void, half the urine was placed into a bottle containing 9 ml
of 6 N HCI and 1.5 mg of pepstatin, while the other half of the
urine was stored untreated. Kinin measurements in the urine
collected in this way are stable for at least 18 months [19].
Following completion of the high sodium phase, the effect of
acute sodium or water loading was investigated on separate
days, respectively, with a day of rest between studies. The
order of the sodium or water loads was randomized. On each
day of study, subjects were upright between 7:00 a.m. and 4:00
p.m. and ate a light breakfast at 7:30 a.m. One hundred ml of
water was given orally each hour between 7:00 a.m. and 11:00
a.m., and 12:00 noon and 3:00 p.m. Hourly urines were col-
lected between 8:00 a.m. and 4:00 p.m. The total volume of
each hourly urine sample was measured. Two aliquots were
obtained: one for kallikrein, aldosterone, electrolyte and creat-
mine measurements, and one for kinin and kininogen determi-
nations (acid and pepstatin treated). At 11:00 a.m. either 20 ml
of water/kg body weight was given orally or 2 liters of 0.9%
sodium chloride was given intravenously over one hour. Blood
for plasma aldosterone and electrolyte measurement was ob-
tained at 9:30 a.m. and 1:30 p.m.
Assays
Urinary kallikrein radioimmunoassay. Purified human uri-
nary kallikrein and rabbit anti-human urinary kallikrein serum
was supplied by Dr. Narendra B. Oza, Boston, Massachusetts.
The radioimmunoassay procedure, measuring total (active and
inactive) kallikrein has been previously described [20, 21].
Urinary kinin radioimmunoassay. Determination of kinins in
urine was performed by radioimmunoassay using a highly
specific rabbit antibradykinin serum supplied by Dr. Cohn
Johnson, Melbourne, Australia as previously reported [19, 20].
The cross reactivity between bradykinin antiserum and puri-
fied, human low—molecular—weight kininogen, supplied by Drs.
Jack Pierce and John Pisano, Bethesda, Maryland, was 3%.
Determination of kininogen excretion
Total urinary kinin was measured following trypsinization of
urine as previously described [19, 20]. Intact kininogen in each
sample was then calculated from the difference between the
kinins generated after trypsinization and the kinins measured in
the absence of trypsin. The intact kininogen was reported as tg
of kinins/day. This method of calculating kininogen excretion
agrees well with radioimmunoassay measurements of urinary
kininogen using specific anti-kininogen antibody [22, 23].
Other analysis
Plasma renin activity was determined using the GammaCoat
plasma renin activity radioimmunoassay kit (Clinical Assays,
Cambridge, Massachusetts, USA). Urinary and plasma aldo-
sterone were measured by radioimmunoassay using the Coat—
A—Count solid phase radioimmunoassay kit (Diagnostic Prod-
ucts, Los Angeles, California, USA). Urinary sodium and
potassium were measured by flame photometry using lithium as
an internal standard and creatinine in urine was measured by
the Jaffe rate method.
Statistics
The effects of chronic dietary sodium manipulation on com-
ponents of the renal KKK system were evaluated using multiple
analysis of variance (MANOVA) [24]. After multivariate anal-
ysis established a significant overall effect between the high and
low sodium groups, the use of univariate analysis, ANOVA,
then located statistically significant variables [24]. Covariate
analysis, ANCOVA, was used to control for specific variables
and to assess the differences between the high and low sodium
intakes [25]. Multiple correlations were performed to evaluate
the interactions between variables.
The effect of acute sodium and water loading on components
of the urinary KKK system was tested using MANOVA and
one way analysis of variance. Significant experimental periods
for those variables with a main effect for the group were
determined by a-priori contrasts. Data was pooled from three
control and experimental periods following sodium and water
loading. Pearson correlations were computed between the
variables.
Results
Dietary sodium depletion and repletion
Seven patients completed both the chronic high and low salt
phases of the study. For all variables, there were no significant
differences between the mean values in the two collections
obtained at the end of each phase. Therefore, the mean value of
the two consecutive urines was used as an individual data point
for each variable.
Changes in sodium intake were associated with alterations in
urinary sodium excretion, plasma renin activity and urinary
aldosterone excretion and weight as expected (Table I). No
effects on blood pressure, urinary potassium or creatinine
clearance were observed. The mean values for the excretion of
intact kininogen, kinins and kallikrein were significantly higher
in subjects on the low sodium compared to the high sodium
intake (Fig. 1).
The effect of alterations in sodium intake on each component
of the KKK system was reevaluated when urinary aldosterone
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Table 1. The effect of dietary sodium intake in seven normal subjects
P
Parameter Low sodium High sodium value
Systolic blood pressure mm Hg 116 3 116 3 NS
Diastolic blood pressure mm Hg 76 1 72 2 NS
Weight (Kg) 74.3 3.8 75.7 3.6 NS
Plasma renin activity ng/ml/hr 10.88 0.56 1.33 0.54 <0.001
Urinary aldosterine sg/day 42.9 5.5 3.2 0.20 <0.001
Urinary sodium mEqlday 6 2 231 18 <0.001
Urinary potassium mEq/day 56 3 55 5 NS
Urine flow rate liter/day 1.014 0.096 1.200 .089 NS
Urine creatinine g/day 1.28 0.09 1.29 0.08 NS
Data are mean SEM.
Parameter
Urinary kinin excretion
Ra P value
Intact kininogen jg kinin/day
Kallikrein pg/day
Urine flow liter/day
Urine sodium mEqlday
Urine potassium mEq/day
0.59
0.22
—0.17
—0.42
0.21
0.002
NS
NS
0.023
NS
Correlation coefficient
was used as a covariate. This was done because of the in vitro
evidence that aldosterone may directly stimulate the synthesis
of kallikrein [261. With this covariant analysis, previously
significant effects of sodium intake on total kallikrein and intact
kininogen was eliminated. This suggests that these changes may
be secondary to the alterations in aldosterone or some addi-
tional factor related to the experimental procedures which also
affects aldosterone.
Table 2 presents the results of multiple correlations using all
measurements obtained during the chronic phases of the study
(N 28). Kinin excretion was significantly correlated to the
excretion of intact kininogen and sodium but not kallikrein,
potassium or urine volume.
P
Before After value
Systolic blood pressure mm Hg 113 2 118 3 NS
Diastolic blood pressure mm Hg 72 2 78 3 NS
Plasma aldosterone ng/mI 7.99 0.62 3.81 0.64 <0.001
Urine sodium p.Eq/min 129.0 10.8 270.3 10.3 <0.001
Urine potassium p.Eq/min 56.1 4.7 71.5 7.8 NS
Urine flow mI/mm 1.6 0.3 3.7 0.5 0.001
Kinins ng/min 12.9 1.8 7.9 1.7 <0.037
Intact kininogen ng kinin/min 7.6 1.2 10.2 2.4 NS
Kallikrein nglmmn 52.98 4.07 33.79 3.98 <0.002
Data are mean SEM.
P
Before After value
Systolic blood pressure mm Hg 119 2 118 3 NS
Diastolic blood pressure mm Hg 77 2 74 2 NS
Plasma aldosterone ng/ml 6.89 0.57 5.71 0.68 NS
Urine sodium EqImin 126.3 12.3 108.6 14.5 NS
Urine potassium p.Eq/min 55.4 5.5 43.4 5.8 NS
Urine flow mI/mm 1.3 0.3 6.2 0.7 <0.001
Kinins ng/min 13.0 2.2 8.8 2.8 NS
Intact kininogen ng kinin/min 13.7 4.4 3.6 0,9 0.017
Kallikrein ng/mmn 62.19 9.72 40.97 9.73 NS
Data are mean SEM.
Acute saline and water loading
For the acute studies, the mean of the three control periods
(8:00 a.m. to 11:00 a.m.) was compared to the mean of three
hourly experimental periods (12:00 noon to 3:00 p.m.). During
acute saline loading there was a significant increase in urinary
sodium and flow but urinary creatinine, potassium and blood
pressure were unchanged (Table 3). Acute saline loading pro-
duced a significant decrease in kallikrein and kinin excretion
while the excretion of intact kininogen was not affected signif-
icantly.
Acute water loading was also associated with an increase in
urine flow but there were no significant changes in the urinary
excretion of sodium, potassium, and creatinine and blood
pressure was not affected (Table 4). Acute water loading
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Table 3. Effect of acute saline loading in nine normal subjects20
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Fig. 1. The effect of chronic alteration in sodium intake on components
of the renal kallikrein—kininogen—kinin system in normal subjects. LS =
low sodium diet; HS = high sodium diet. Urinary excretion levels are
in sg/day. The thin lines connect the data for each individual. The thick
line is the mean level of each component SEM. * - P < 0.05.
Table 2. Correlations between urinary kinin excretion and parameters
studied in normal subjects during high and low sodium diets
Table 4. Effect of acute water loading in eight normal subjects
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produced a decrease in the excretion of all components of the
KKK system although only the fall in kininogen excretion
reached statistical significance.
Discussion
A physiologic role for intrarenal kinins in the regulation of
sodium and water excretion has been suggested by a number of
experimental observations. Infusion of bradykinin into the renal
artery leads to an increase in ipsilateral sodium excretion [27,
28]. Microinjection of bradykinin into the lumen of the late
proximal tubule decreases the reabsorption of sodium in distal
nephron segments and results in a net increase in sodium
excretion [29]. These pharmacologic effects of exogenous
kinins indicate that either directly or indirectly, kinins are
associated with an inhibition of sodium reabsorption. During an
increase in sodium intake, the inhibition of tubular sodium
reabsorption is an appropriate physiologic adjustment to main-
tain sodium balance. Thus it might be expected that during a
high sodium intake, urinary kinins would increase in parallel
with the increase in sodium excretion if the renal KKK system
played a role in the adjustment of renal sodium excretion to
sodium intake. A positive correlation between fractional so-
dium excretion and urinary kallikrein activity and kinin excre-
tion has been noted in man on an unrestricted diet [30, 31].
However, such a correlation has not been consistently found
during experimental manipulations of dietary sodium [1, 2,
15—17].
This lack of agreement on the effects of changes in sodium
intake on urinary kinin excretion in man led us to reevaluate
this issue using both acute and chronic sodium loads in the same
individuals. In addition, we evaluated other components of the
KKK system to better delineate the mechanisms by which
changes in kinin excretion occurred. Our results indicate that
during both chronic and acute sodium loading, urinary kinin
excretion is suppressed. This observation does not appear to be
the result of changes in urinary flow rate as no increase in flow
rate was observed in the chronic study.
Our observations are in contrast to other reports of either no
change or an increase in kinin excretion during dietary salt
loading [11, 13, 32]. Differences in the methodology for the
urine collections and kinin measurements may account for
some of this discrepancy. For example, urine was not treated
with HCI-pepstatin in the previously reported studies and this
may have affected the preservation of kinins. In addition,
patient population, sodium intake, collection time, and the
activity of the mineralocorticoid system may also have contrib-
uted to these different results. The independent observation
that substrate and enzyme excretion were suppressed in parallel
with kinin excretion leads us to believe that our results are
biochemically consistent.
What do these observations mean for a putative role of the
renal KKK system in the regulation of sodium balance? While
the fall in urinary kinin excretion during both acute and chronic
sodium loading argues against a primary natriuretic role for this
system, it is possible that intrarenally generated kinins modu-
late the effects of other vasopressor and antinatriuretic systems
activated during changes in sodium balance. This speculation is
raised for a number of reasons. First, bradykinin is known to
inhibit the vasopressor effect of noradrenalin and angiotensin II
[33]. In the present study we found that urinary kinin excretion
changed in parallel with plasma renin activity (r = 0.61; P <
0.05) and similar observations have been reported by others [18,
32, 34, 35]. Furthermore, bradykinin is known to activate the
renal synthesis of prostaglandins, a vasodilatory and natriuretic
system also postulated to play a similar modulating role when
vasoactive—anti-natriuretic systems are activated [36, 37]. The
precise physiologic role of kinin in low sodium states (during
which the KKK system appears to be activated) can not be
addressed by our experiments. We believe, however, that our
observations exclude a role for urinary kinins in contributing to
the enhanced natriuresis which accompanies high sodium in-
takes.
In addition to the physiologic importance of kinins during
changes in sodium intake, our data provides new insights into
the regulation of urinary kinin excretion. The enzyme, kal-
likrein, has long been recognized as a primary determinant of
kinin formation and the measurement of urinary kallikrein
excretion has been assumed to reflect the intrarenal activity of
the KKK system. However, as already mentioned, most acute
and chronic studies have found a poor correlation between
simultaneously—measured total kallikrein and kinin excretion
[1,2, 7], a finding confirmed in the present study (r = 0.22). This
is not totally unexpected as a number of additional factors such
a kallikrein activity, substrate concentrations, and urinary
kininase activity are known to be important in kinin excretion.
We believe, however, that our method of collecting the urine in
this study minimizes any potential influence of urinary
kininases on the results.
Kallikrein appears in the urine in both an inactive and active
form. In man, approximately 40% of total kallikrein excretion is
in the active form [21]. Changes in the percentage of active kal-
likrein have not been extensively evaluated during dietary salt
manipulation [1, 2, 21]. Since we did not specifically measure
active kallikrein, we cannot exclude alteration in active kal-
likrein excretion from influencing kinin excretion. However,
even when active kallikrein has been measured during balance
studies, a correlation with simultaneously—measured kinin ex-
cretion has not been consistently found [18, 38]. In the present
study, during all of the conditions in which urinary kinin
excretion fell, a fall in total kallikrein excretion was also seen.
Although this fall did not reach statistical significance in all
cases, it is possible that larger groups and/or measurements of
kallikrein activity would have revealed significant changes.
Substrate levels may also influence kinin formation. The
substrate from which urinary kinin is derived is a low
molecular—weight kininogen which is synthesized by the liver
and appears in the urine as a result of glomerular filtration [39,
40]. Our laboratory previously reported a significant correlation
between simultaneously—measured urinary kinin and intact
kininogen excretion in normal volunteers on an unrestricted
diet [19]. The urinary kininogen excretion paralleled urinary
kinin excretion over a wide range of dietary sodium intakes.
The kininogen levels in the urine were approximately 500- to
1000-fold below the km for the reaction with kallikrein, and thus
we suggested that they were a rate limiting factor in kinin
formation [19, 22, 23, 30, 41, 42].
In the present study, intact kininogen excretion was also
correlated to kinin excretion during both chronic and acute
alterations in sodium intake (r = 0.59, P < 0.002). While we
recognize that correlations do not guarantee causal relation-
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ships, there is no evidence that kinins can be formed in the urine
from any other substrate. Therefore, the correlation between
kininogen and kinin excretion reflects this biochemical reality
and does indicate a cause and effect relationship. Additionally,
we found that urinary intact kininogen fell only during steady
state changes in sodium intake. The fall in intact kininogen
during chronic dietary sodium loading could result from a
decrease in the filtered toad of kininogen or an increase in its
degradation within the urine. However, if an increase in degra-
dation was the primary mechanism, we might have expected an
increase in the degradation product, kinin, in the urine. This
was not found and in fact kinin excretion also fell. Thus a
decrease in the filtered load of kininogen is suggested. Unfor-
tunately, plasma kininogen was not measured in this study.
Intact kininogen excretion also fell during the acute water
load. Kinin levels again fell but not significantly. Whether this
reduction is a result of the large water flow and is of some phys-
iologic significance is unknown.
Covariate analysis indicates that both kallikrein and intact
kininogen excretion are correlated to aldosterone excretion. A
causal relationship between aldosterone and urinary kallikrein
has been previously described [1, 2]. In vitro stimulation of
kallikrein release by mineralocorticoids has been demonstrated
in renal cortical cell suspensions and slices suggesting a direct
effect [26]. Our data suggests that mineralocorticoids may also
influence the excretion of kininogen as well. In view of the
arguments suggesting a decrease in the filtered load of kinin-
ogen, further studies on a possible effect of aldosterone on
kininogen synthesis should be considered.
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